Production (Stage)
Milestone Pharmaceuticals Inc.
MIST
$1.73
-$0.01-0.58%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 5.74% | 30.44% | 27.82% | 17.57% | 7.15% |
| Total Depreciation and Amortization | 6.09% | 8.03% | 29.45% | 28.42% | 28.00% |
| Total Amortization of Deferred Charges | 16.31% | 51.64% | 123.13% | 327.50% | -- |
| Total Other Non-Cash Items | -29.08% | -28.43% | -22.80% | 2.59% | 26.13% |
| Change in Net Operating Assets | 485.76% | 194.13% | 188.38% | 238.61% | 165.01% |
| Cash from Operations | 18.30% | 37.86% | 35.74% | 24.46% | 20.93% |
| Capital Expenditure | 51.25% | 70.54% | 78.01% | 79.71% | 73.68% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 232.17% | 70.83% | 110.36% | 53.98% | -176.61% |
| Cash from Investing | 231.89% | 74.16% | 110.12% | 54.21% | -172.64% |
| Total Debt Issued | -- | -- | -100.00% | -100.00% | -100.00% |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -99.15% | 4,668.56% | 3,331.93% | 780.66% | 750.06% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -102.51% | 265.48% | 265.48% | 265.48% | -- |
| Cash from Financing | -100.20% | -32.79% | -33.16% | -35.84% | -43.97% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 154.77% | 88.67% | 110.65% | 36.93% | -248.98% |